MAINZ BIOMED N.V. - Ordinary Shares, (euro)0.01 nominal value (MYNZ)
CUSIP: N5436L101
Q2 2024 13F Holders as of 30 Jun 2024
- Type / Class
- Equity / Ordinary Shares, (euro)0.01 nominal value
- Shares outstanding
- 489,733,060
- Total 13F shares
- 103,313
- Share change
- -43,454
- Total reported value
- $41,429
- Price per share
- $0.40
- Number of holders
- 9
- Value change
- -$33,055
- Number of buys
- 1
- Number of sells
- 7
Quarterly Holders Quick Answers
What is CUSIP N5436L101?
CUSIP N5436L101 identifies MYNZ - MAINZ BIOMED N.V. - Ordinary Shares, (euro)0.01 nominal value in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Next holder-history checks
These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.
- Back to full security ownership history for the broader multi-quarter picture.
- Latest 13F filings for newly reported positions across managers.
- Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
- SEC investors directory for manager drilldown.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
Recent filing periods for CUSIP N5436L101:
Top shareholders of MYNZ - MAINZ BIOMED N.V. - Ordinary Shares, (euro)0.01 nominal value (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| NORTHERN TRUST CORP |
13F
|
Company |
0.01%
|
29,934
|
$30,832 | — | 31 Mar 2024 | |
| XTX Topco Ltd |
13F
|
Company |
0.01%
|
28,776
|
$29,639 | — | 31 Mar 2024 | |
| Vontobel Holding Ltd. |
13F
|
Company |
0.01%
|
25,000
|
$25,750 | — | 31 Mar 2024 | |
| CITADEL ADVISORS LLC |
13F
|
Company |
0%
|
18,157
|
$18,702 | — | 31 Mar 2024 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
0%
|
15,189
|
$15,644 | — | 31 Mar 2024 | |
| Greenwich Investment Management, Inc. |
13F
|
Company |
0%
|
11,984
|
$12,000 | — | 31 Mar 2024 | |
| MORGAN STANLEY |
13F
|
Company |
0%
|
10,247
|
$10,554 | — | 31 Mar 2024 | |
| UBS Group AG |
13F
|
Company |
0%
|
3,207
|
$3,303 | — | 31 Mar 2024 | |
| NORTHWESTERN MUTUAL WEALTH MANAGEMENT CO |
13F
|
Company |
0%
|
2,500
|
$2,575 | — | 31 Mar 2024 | |
| NewEdge Advisors, LLC |
13F
|
Company |
0%
|
1,000
|
$1,030 | — | 31 Mar 2024 | |
| CITIGROUP INC |
13F
|
Company |
0%
|
673
|
$693 | — | 31 Mar 2024 | |
| BANK OF AMERICA CORP /DE/ |
13F
|
Company |
0%
|
100
|
$103 | — | 31 Mar 2024 |
Institutional Holders of MAINZ BIOMED N.V. - Ordinary Shares, (euro)0.01 nominal value (MYNZ) as of Q2 2024
As of 30 Jun 2024,
MAINZ BIOMED N.V. - Ordinary Shares, (euro)0.01 nominal value (MYNZ) was held by
9 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
103,313 shares.
The largest 9 holders included
NORTHERN TRUST CORP, Vontobel Holding Ltd., GEODE CAPITAL MANAGEMENT, LLC, XTX Topco Ltd, Greenwich Investment Management, Inc., Wealth Quarterback LLC, CITIGROUP INC, MORGAN STANLEY, and BANK OF AMERICA CORP /DE/.
This page lists
9
institutional shareholders reporting positions in this security
for the Q2 2024 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q2 2024 vs Q1 2024 Across Filers
Q1 2024 holders
12
Q2 2024 holders
9
Holder diff
-3
| Investor | Q1 2024 Shares | Q2 2024 Shares | Share Diff | Share Chg % | Q1 2024 Value $ | Q2 2024 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.